Results 1 to 10 of about 25,643 (121)

A Case of Cryobiopsy of a Large Allergic Bronchopulmonary Aspergillosis‐Associated Mucus Plug [PDF]

open access: yesRespirol Case Rep
We report a rare case of an allergic bronchopulmonary aspergillosis‐associated large mucus plug that was removed by cryobiopsy. When grasped during forceps biopsy, mucus plugs, which are soft tissue, can collapse, making them difficult to remove. Cryobiopsy is a more suitable way to remove mucus plugs because it freezes the plugs, allowing them to be ...
Nakamura Y   +7 more
europepmc   +2 more sources

Immunotherapy of aspergillosis [PDF]

open access: yesClinical Microbiology and Infection, 2012
Management of invasive aspergillosis in high-risk patients remains challenging. There is an increasing demand for novel therapeutic strategies aimed at enhancing or restoring antifungal immunity in immunocompromised patients. In this regard, modulation of specific innate immune functions and vaccination are promising immunotherapeutic strategies ...
Cristina Cunha   +4 more
openaire   +4 more sources

Treatment of Aspergillosis [PDF]

open access: yesJournal of Fungi, 2018
Infections caused by Aspergillus spp. remain associated with high morbidity and mortality. While mold-active antifungal prophylaxis has led to a decrease of occurrence of invasive aspergillosis (IA) in those patients most at risk for infection, breakthrough IA does occur and remains difficult to diagnose due to low sensitivities of mycological tests ...
Jeffrey D. Jenks, Martin Hoenigl
openaire   +6 more sources

Invasive aspergillosis [PDF]

open access: yesMedical Mycology, 2000
Item does not contain ...
Verweij, P.E.   +6 more
openaire   +2 more sources

Clinical periodontal diagnosis

open access: yesPeriodontology 2000, EarlyView., 2023
Abstract Periodontal diseases include pathological conditions elicited by the presence of bacterial biofilms leading to a host response. In the diagnostic process, clinical signs such as bleeding on probing, development of periodontal pockets and gingival recessions, furcation involvement and presence of radiographic bone loss should be assessed prior ...
Giovanni E. Salvi   +5 more
wiley   +1 more source

Immunodiagnosis of aspergillosis [PDF]

open access: yesClinical Microbiology Reviews, 1991
Aspergillus species are ubiquitous fungi and have been implicated as the causative agents of a variety of lung disorders in humans. These disorders include allergic, saprophytic, and systemic manifestations. The allergic disorders mainly affect atopic persons, and invasive or systemic diseases affect immunosuppressed individuals.
V. K. Kurup, Anoopa Kumar
openaire   +3 more sources

Destructive aspergillosis

open access: yesIndian Journal of Otolaryngology and Head and Neck Surgery, 2005
The incidence of mycotic infections of paranasal sinuses is on the rise. Aspergillosis is the commonest fungal infection involving the nose and paranasal sinuses. This disease has a varied presentation ranging from the allergic form to the more deadly invasive or destructive form.
Nitin M. Nagarkar   +4 more
openaire   +4 more sources

Pulmonary aspergillosis

open access: yesDiagnostic and Interventional Imaging, 2015
Aspergillosis is a mycotic disease usually caused by Aspergillus fumigatus, a saprophytic and ubiquitous airborne fungus. Aspergillus-related lung diseases are traditionally classified into four different forms, whose occurrence depends on the immunologic status of the host and the existence of an underlying lung disease.
Chabi, M.L.   +5 more
openaire   +2 more sources

Promising Prodiginins Biological Activities

open access: yesChemistry &Biodiversity, EarlyView.
ABSTRACT Prodiginins are a large family of at least 34 pyrrolic compounds, including the well‐studied red pigment prodigiosin. Prodiginins are produced by several microorganisms displaying broad biological activities, including antimicrobial, antiviral, antiparasitic, antiproliferative, and immunosuppressive activities.
María F. Ladetto   +6 more
wiley   +1 more source

Implementing Pre‐Emptive Pharmacogenetics: Impact of Early Pharmacogenetic Screening in a Pediatric Oncology Cohort of 1,151 Subjects

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
In pediatric oncology, pharmacogenetic guidelines are underutilized and the potential impact of pre‐emptive pharmacogenetic screening remains largely unexplored despite this field's need for individualized approaches. While comprehensive pharmacogenetic guidelines are not yet available for all anticancer drugs, evidence‐based recommendations exist for ...
Emma C. Bernsen   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy